228 related articles for article (PubMed ID: 20061048)
1. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
[TBL] [Abstract][Full Text] [Related]
2. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
[TBL] [Abstract][Full Text] [Related]
3. Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation.
Lisi S; Sisto M
Immunol Cell Biol; 2010; 88(3):297-304. PubMed ID: 19949420
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands.
Sisto M; D'Amore M; Caprio S; Mitolo V; Scagliusi P; Lisi S
Ann N Y Acad Sci; 2009 Aug; 1171():407-14. PubMed ID: 19723083
[TBL] [Abstract][Full Text] [Related]
6. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
Lisi S; Sisto M; Lofrumento DD; D'Amore M
Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome.
Sisto M; D'Amore M; Lofrumento DD; Scagliusi P; D'Amore S; Mitolo V; Lisi S
Int Immunol; 2009 Mar; 21(3):303-11. PubMed ID: 19190085
[TBL] [Abstract][Full Text] [Related]
8. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
9. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
10. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
[TBL] [Abstract][Full Text] [Related]
11. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
12. Targeting TNF-α suppresses the production of MMP-9 in human salivary gland cells.
Aota K; Azuma M
Arch Oral Biol; 2013 Dec; 58(12):1761-8. PubMed ID: 24200302
[TBL] [Abstract][Full Text] [Related]
13. Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands.
Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Mitolo V; D'Amore M
Histochem Cell Biol; 2010 Oct; 134(4):345-53. PubMed ID: 20811902
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
[TBL] [Abstract][Full Text] [Related]
15. Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjögren's syndrome.
Namekawa T; Kuroda K; Kato T; Yamamoto K; Murata H; Sakamaki T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Rheumatol; 1995 Nov; 22(11):2092-9. PubMed ID: 8596150
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
Mavragani CP; Tzioufas AG; Moutsopoulos HM
Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
[TBL] [Abstract][Full Text] [Related]
17. Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjögren's syndrome.
Reed JH; Dudek NL; Osborne SE; Kaufman KM; Jackson MW; Purcell AW; Gordon TP
Arthritis Rheum; 2010 May; 62(5):1448-56. PubMed ID: 20131295
[TBL] [Abstract][Full Text] [Related]
18. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
[TBL] [Abstract][Full Text] [Related]
19. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
20. Lupus/Sjögren's autoantibody specificities in sera with paraproteins.
Sestak AL; Harley JB; Yoshida S; Reichlin M
J Clin Invest; 1987 Jul; 80(1):138-44. PubMed ID: 3496360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
